<p>The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease</p>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease

Published:2019-07 Issue: Volume:Volume 13 Page:2249-2270
ISSN:1177-8881
Container-title:Drug Design, Development and Therapy
language:en
Short-container-title:DDDT

Author:

Zhang Dan-Ying,Zhu Lin,Liu Hai-Ning,Tseng Yu-Jen,Weng Shu-Qiang,Liu Tao-Tao,Dong Ling,Shen Xi-Zhong

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abelmoschi Corolla polysaccharides and related metabolite ameliorates colitis via modulating gut microbiota and regulating the FXR/STAT3 signaling pathway;International Journal of Biological Macromolecules;2024-10

2. FXR agonists in NASH treatment;Journal of Hepatology;2023-11

3. Gut microbiome and metabolic-associated fatty liver disease: Current status and potential applications;World Journal of Hepatology;2023-07-27

4. Bile Acids, Intestinal Barrier Dysfunction, and Related Diseases;Cells;2023-07-19

5. Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus;Frontiers in Endocrinology;2023-05-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP